Investigational Live Biotherapeutic Product Significantly Reduces Risk of Recurrent Clostridioides difficile
In findings published this week, the investigational therapy, VE303, which is being developed for recurrent Clostridioides difficile infection (rCDI) demonstrated it was able to reduce the chance of recurrence by more than 80% compared to placebo in its phase 2 CONSORTIUM study.1 “Due to VE303’s precisely known, defined composition, we can study its mechanisms of […]
Valley Fever Spreads as Conditions Change
George Thompson, MD, professor of infectious disease at UC Davis Medical Center, has been tracking the increase in coccidioidomycosis (Valley fever) and discussing the current trends and contributing factors. “We’ve seen a big increase in the number of cocci cases over the last two to three years. The central valley looks like there may even […]
Opting for Oral Over Intravenous Antibiotic for Acute Skin Infection
Image credit: Pexels, Gustavo Fring Oral dosing of omadacyline or linezolid was found equally efficacious to intravenous administration in treating acute bacterial skin and skin structure infections (ABSSSI) in a post hoc analysis of two trials that compared safety and efficacy of the 2 antibiotics.1 “Oral therapy can reduce the need for hospitalization or the […]
Communicable disease threats report, 18
Marburg virus disease Marburg virus disease, formerly known as Marburg haemorrhagic fever, is a severe disease in humans. Although the disease is uncommon, it has the potential to cause epidemics with significant case fatality rates. Read more Source link
Invisible Until It’s Too Late
In 2015, fungal infections affected over 1 billion people globally each year, leading to an estimated 11.5 million life-threatening infections and more than 1.5 million deaths annually. Despite their significant impact, fungal diseases have historically been under-recognized and underfunded in global health efforts. In response, the Global Action Fund for Fungal Infections (GAFFI) launched a […]
